A B C D E F G H I J K L M N O P Q R S T U V W X Y Z

Doxazosin Impurity 4 | CAS 26961-27-3 - Request Quote

Picture of Doxazosin Impurity 4

Doxazosin Impurity 4

SZ CAT No:SZ-D007015
CAS No
26961-27-3
Mol.F.
C9H10N2O2
Mol.Wt.
178.2
Inv. Status
Synthesis on demand

Chemical Name :

Shipping Temperature :

HSN Code :

Country of Origin :

Smiles :

CHNS Ratio (%) :

Usage Note:

Doxazosin Impurity 4 is chemically 2-Amino-4,5-dimethoxybenzonitrile. Doxazosin Impurity 4 is supplied with detailed characterization data compliant with regulatory guideline. Doxazosin Impurity 4 can be used for the analytical method development, method validation (AMV), Quality Controlled (QC) application for Abbreviated New Drug Application (ANDA) or during commercial production of Doxazosin.

The product can be used as reference standards and further traceability against pharmacopeial standards (USP or EP) can be provided based on feasibility. SynZeal products are for analytical purpose only and not for human use.

Applications & Regulatory Use Cases

Buy 26961-27-3

Purchase 26961-27-3

Order 26961-27-3

Enquire 26961-27-3

price of 26961-27-3

26961-27-3 Supplier

26961-27-3 Manufacturer

26961-27-3 Exporter

buy high quality Doxazosin Impurity 4

Purchase Doxazosin Impurity 4

Doxazosin Impurity 4 suppliers

Doxazosin Impurity 4 manufacturers

Doxazosin Impurity 4 price

Order Doxazosin Impurity 4

Enquire Doxazosin Impurity 4

Doxazosin Impurity 4 cost

Doxazosin Impurity 4 Supplier

Doxazosin Impurity 4 Distributor

Doxazosin Impurity 4 for Method Validation

Doxazosin Reference Standard

Doxazosin Impurity 4 for ANDA Filing

Doxazosin Impurity 4 for Forced Degradation Studies

Doxazosin Impurity 4 Identification Standards

Doxazosin Impurity 4 for DMF Filing

ℹ️

Disclaimer

SynZeal product information given on this website is as per the existing understanding while publishing the details on website. The customer is responsible for assessing the accuracy of the information at the time of actual purchase.

SynZeal will update these details as per new developments or findings in product specifications without further notice.